We are live on ! Find out more
LSTA icon

Lisata Therapeutics
LSTA

33 hedge funds and large institutions have $13.6M invested in Lisata Therapeutics in 2013 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 7

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

13% more capital invested

Capital invested by funds: $12M → $13.6M (+$1.61M)

6% more funds holding

Funds holding: 31 → 33 (+2)

82% less call options, than puts

Call options by funds: $98K | Put options by funds: $557K

Holders
33
Holders Change
+2
Holders Change %
+6.45%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
12
Reduced
7
Closed
8
Calls
$98K
Puts
$557K
Net Calls
-$459K
Net Calls Change
-$532K

Top Buyers

Rank Fund Capital Flow
1
PRCM
Pine River Capital Management
Minnesota
+$2.51M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$983K
3
SC
Sophrosyne Capital
New York
+$462K
4
US Bancorp
US Bancorp
Minnesota
+$329K
5
California Public Employees Retirement System
California Public Employees Retirement System
California
+$198K

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$672K
2
Morgan Stanley
Morgan Stanley
New York
-$384K
3
OAM
Oxford Asset Management
United Kingdom
-$322K
4
Renaissance Technologies
Renaissance Technologies
New York
-$257K
5
CS
Credit Suisse
Switzerland
-$105K
Name Holding Trade Value Shares
Change 		Change in
Stake
JIC
26
Joel Isaacson & Co
New York
$11K +$10.9K +11 New
AllianceBernstein
27
AllianceBernstein
Tennessee
$6K +$4.94K +5 +500%
U
28
UBS
Switzerland
$3K -$50.4K -51 -93%
Northwestern Mutual Wealth Management
29
Northwestern Mutual Wealth Management
Wisconsin
$3K +$2.97K +3 New
Ameriprise
30
Ameriprise
Minnesota
$2K -$989 -1 -33%
Barclays
31
Barclays
United Kingdom
$1K -$71.2K -72 -99%
Wells Fargo
32
Wells Fargo
California
$1K – – –
Manulife (Manufacturers Life Insurance)
33
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$11 +$9.89K +10 +1,000%
Renaissance Technologies
34
Renaissance Technologies
New York
– -$257K -200 Closed
CS
35
Credit Suisse
Switzerland
– -$105K -82 Closed
PP
36
Paloma Partners
Connecticut
– -$94K -73 Closed
Nomura Holdings
37
Nomura Holdings
Japan
– -$90K -70 Closed
Deutsche Bank
38
Deutsche Bank
Germany
– -$35K -27 Closed
BIT
39
BlackRock Institutional Trust
California
– -$26K -20 Closed
PCM
40
Prelude Capital Management
New York
– -$15K -12 Closed
Creative Planning
41
Creative Planning
Kansas
– -$989 -1 Closed
1
2

LSTA Hedge Fund Activity: Q4 2013 in Review

33 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q4 2013, worth a combined $13.6M — up 13% from $12M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new LSTA positions and 8 closed out — a net gain of 2 holders — while 12 added to existing stakes and 7 trimmed.

The largest buyer was Pine River Capital Management, opening a new position worth an estimated $2.51M. The largest seller was Perceptive Advisors, cutting an estimated $672K.

  • 33 institutional investors held Lisata Therapeutics (LSTA) as of Q4 2013, up from 31 in Q3 2013.
  • Funds reported $13.6M of Lisata Therapeutics stock for Q4 2013, up 13% quarter-over-quarter.
  • 10 funds opened new Lisata Therapeutics positions in Q4 2013 and 8 closed out, a net change of +2 holders.
  • The largest Lisata Therapeutics buyer in Q4 2013 was Pine River Capital Management, an estimated $2.51M added.
  • The largest Lisata Therapeutics seller in Q4 2013 was Perceptive Advisors, an estimated $672K sold.

Based on aggregated 13F filings for Q4 2013.